Other common side effects with BRILINTA include dizziness, nausea, diarrhea, slow heartbeat rate, rash, and allergic reactions including swelling of the face, throat, lips, tongue, hands, or feet.
Brilinta, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with – acute coronary syndromes (ACS) or – a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event. Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.